Research Article
Renal Evaluation in Common Variable Immunodeficiency
Table 2
Demographic and clinical data of CVID patients and subjects controls.
| | CVID patients | Control | |
| | Age (years) | 32.4 ± 4.1 | 31.6 ± 1.8 | 0.8 | | GFR (mL/min/1.73 m2) | 121.0 ± 10.4 | 112.2 ± 2.8 | 0.8 | | Albumin/creatinine excretion rate (mg/g) | 4.4 ± 1.1 | 3.1 ± 1.1 | 0.04 | | (%) | 0.9 ± 0.5 | 0.5 ± 0.1 | 0.5 | | (%) | 7 ± 3.3 | 5.6 ± 0.8 | 0.2 | | (%) | 7.9 ± 0.4 | 7.4 ± 0.1 | 0.1 | | (%) | 1.5 ± 7.7 | 9.0 ± 0.1 | 0.4 | | U/Osm | 2.5 ± 0.2 | 3.4 ± 0.1 | <0.001 | | Urinary MCP-1 (pg/mg-Cr) | 48 ± 14.5 | 42.1 ± 7.1 | 0.7 |
|
|
FE: fractional excretion.
|
